Merrill LynchâÂÂs buyout unit, in partnership with a fledgling venture capital firm run by former executives from biotechnology group Serono, has won the fiercely competitive auction for Hungarian healthcare group Euromedic International.
Merrill Lynch Global Private Equity, which is targeting $6bn for its next buyout fund, and venture start-up Ares Life Sciences paid â¬800m ($1.2bn) in equity for the Warburg Pincus-owned business, according to deal sources.
